EBEsther BayigaPhD(c)SlidesetHIVINTEREST 2022Second Speaker Against the Proposition - Esther Bayiga, PhD(c)View Slideset
SlidesetHIVINTEREST 2022Low-Level of Archived Resistance to Integrase Inhibitors Among Third-Line Patients...Future Therapeutics - Ezechiel Ngoufack Jagni SemengueView Slideset
LCLameck ChinulaMDSlidesetHIVINTEREST 2021Preventing Cervical Cancer among Women Living with HIV in Low-and-Middle - Lameck Chinula,MDView Slideset
MDMeg DohertyMD, PhDSlidesetHIVINTEREST 2021Charles Boucher Memorial Lecture – How Treatment Has Evolved – 2000 Until Now - Meg Doherty, MD, PhDView Slideset
JBNJean B. NachegaMD, PhD, MPH, FRCP, FAASSlidesetHIVINTEREST 2021HIV and COVID-19 Considerations - Jean Nachega, MD, PhD, MPH, FRCP, FAASView Slideset
PMPaula MunderiMD, FRCPSlidesetHIVINTEREST 2021Global HIVAIDS Update UNAIDS Strategy to End AIDS in 2030 - Paula Munderi, MD, FRCPView Slideset
DMDorothy Mbori-NgachaMBChB, MMed, MPHSlidesetHIVINTEREST 2021Elimination of HIV in Children - Dorothy Mbori-Ngacha, MBChB, MMedView Slideset
SBSabrina Bakeera-KitakaMD, PhDSlidesetHIVINTEREST 2021Diagnosis, Management, and Challenges of ART Treatment Failure in Children and Adolescents - Sabrina Bakeera-Kitaka, MD, PhDView Slideset
LBLinda-Gail BekkerMBChB, DTMH, DCH, FCP(SA), PhDSlidesetHIVINTEREST 2021Charles Boucher Memorial Lecture – Changes in How Services Have Been Delivered - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhDView Slideset
JNJohn NkengasongPhDSlidesetHIVINTEREST 2021Charles Boucher Memorial Lecture – CDC Epidemiology Trends - John Nkengasong, PhDView Slideset
FVFrançois VenterMD, FCP, PhDSlidesetHIVINTEREST 2021What Has the Dolutegravir Era Taught Us - François Venter, MD, FCP, PhDView Slideset
SMSébastien MorinPhDSlidesetHIVINTEREST 2021Accessing Effective Treatments and Prevention Tools at Affordable Prices - Sébastien Morin, PhDView Slideset
